A5040529980- Statistical Methods in Clinical Trials
- Advanced Statistical Process Monitoring
- Optimal Experimental Design Methods
- Drug Solubulity and Delivery Systems
- Biosimilars and Bioanalytical Methods
- Safe Handling of Antineoplastic Drugs
- Quality and Safety in Healthcare
- Pharmaceutical Economics and Policy
- Analytical Methods in Pharmaceuticals
- Technology Assessment and Management
- Biotechnology and Related Fields
- Big Data and Business Intelligence
- Safety Systems Engineering in Autonomy
- Crystallization and Solubility Studies
- Pharmaceutical studies and practices
- Protein purification and stability
- Rocket and propulsion systems research
- Risk and Safety Analysis
- Scientific Measurement and Uncertainty Evaluation
- Health Systems, Economic Evaluations, Quality of Life
- Manufacturing Process and Optimization
- Medical Device Sterilization and Disinfection
- Spectroscopy and Chemometric Analyses
- Granular flow and fluidized beds
- Mineral Processing and Grinding
Alphora Research (Canada)
2018
Apotex (Canada)
2015-2017
The quantitative study investigated factors that influence the initiation, convergence prospects, highest return on investment sector, and variables can delay machine learning artificial intelligence in pharmaceutical industry. population constituted individuals from US FDA sites registry, representing all sectors of reports trends preferences identified by industry executives who participated survey. first hypothesis utilized Kruskal Walli confirming a statistically significant difference...
The objective of the study was to create a reliable method that could be used evaluate particle size distribution samples and pre-mixes in real-world situations, particularly those consisting typical formulation blends. goal use this assess uniformity ensure they met required quality standards. researchers aimed easily incorporated into manufacturing process, providing practical efficient solution.
Ninety per cent of US prescriptions volumes are generic drug products. Solid oral products constitute more than 75% the drugs. The product development and commercialization incorporate complex process steps that need close portfolio management, alignment monitoring. With increased regulatory actions, market insecurity pricing pressures, organizations required to apply evidence based new empirical approaches management. Watergile approach discussed in this article allows adapt, respond evolve...